II. Details: Therapeutic Agents for Chronic Heart Failure; 2. SGLT2 Inhibitor
نویسندگان
چکیده
SGLT2（sodium glucose cotransporter 2）阻害薬は糖尿病に対する血糖降下薬として開発されたが，心血管病リスクを有する2型糖尿病患者に対する心不全入院抑制作用が明らかとなった．それに引き続き，SGLT2阻害薬は，心機能低下を伴う慢性心不全患者の予後改善効果が明らかとなり，さらに最近，収縮力の保持された慢性心不全患者の予後改善効果も示された．現在各国の心不全ガイドラインにおいて心機能低下を伴う心不全患者に対しその使用が推奨されている．
منابع مشابه
A Novel Therapeutic Agent for Type 2 Diabetes Mellitus: SGLT2 Inhibitor
Type 2 diabetes mellitus (T2DM) is a complex endocrine and metabolic disorder, and a major public health problem that is rapidly increasing in prevalence. Although a wide range of pharmacotherapies for glycemic control is now available, management of T2DM remains complex and challenging. The kidneys contribute immensely to glucose homeostasis by reabsorbing glucose from the glomerular filtrate....
متن کاملErythropoiesis-stimulating agents for anaemia in chronic heart failure patients.
BACKGROUND Chronic heart failure (CHF) is a leading cause of morbidity and mortality worldwide. Anaemia is a common (12-55%) co-morbid condition and is associated with worsening symptoms and increased mortality. Anaemia is treatable and can be targeted in the treatment of patients with CHF. Erythropoiesis-stimulating agents (ESA), supplemented by iron therapy, are used to treat anaemia in chron...
متن کاملXanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?
A substantial body of evidence has accumulated to suggest a role for the xanthine oxidase metabolic pathway in the pathophysiology of chronic heart failure and other cardiovascular diseases.
متن کاملSodium-Glucose Transporter Type 2 (SGLT2) Inhibitor for Diabetic Kidney
In diabetes, both activation of renin-angiotensin system and glomerular hyperfiltration are seen even before the development of diabetic nephropathy. Glomerular hyperfiltration depends on glomerular hypertension sue to pathophysiological afferent arteriolar dilation. Tubular hypothesis has been proposed more than a decade ago to explain the above in type1 diabetes. Recently, clinical evidences ...
متن کاملPhosphodiesterase 2 as a Therapeutic Target for Heart Failure
Heart failure (HF) is a chronic progressive cardiac disease with high morbidity and mortality. A key pathophysiological feature of HF is chronic overexcitation of the sympathetic nervous system and release of catecholamines. The subsequent activation of cardiac β-adrenoceptors (β-ARs) results in molecular and structural changes that lead to cardiac hypertrophy, myocardial fibrosis, or electrome...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nihon Naika Gakkai zasshi
سال: 2022
ISSN: ['1883-2083', '0021-5384']
DOI: https://doi.org/10.2169/naika.111.228